MED26

MED26 is a metazoan Mediator subunit that controls the transition of RNA polymerase II from initiation into productive elongation, acting through its conserved N-terminal domain (NTD) as a molecular switch (PMID:21729782). The NTD folds into a four-helix bundle whose H3/H4 groove provides overlapping docking sites for the general initiation factor TFIID (via TAF7) and for ELL/EAF-containing elongation complexes, with both TAF7 and EAF1 peptides binding the same groove by a folding-upon-binding mechanism (PMID:28893534). By first engaging TFIID at the initiation complex and then exchanging TAF7 for ELL/EAF complexes, MED26 facilitates Pol II pause-release: it recruits the super elongation complex (SEC, containing ELL/EAF and P-TEFb) at protein-coding genes (PMID:21729782) and, through direct EAF–NTD contact, recruits the little elongation complex (LEC) to a subset of snRNA genes, where MED26 loss reduces LEC occupancy and snRNA transcription (PMID:25575120). Beyond its elongation role, a conserved C-terminal motif of MED26 binds the chromoshadow domain of heterochromatin protein 1 (HP1), and a fraction of MED26 localizes to pericentric heterochromatin (PMID:24820420). MED26 integrates into core Mediator at a site occluded by the CKM, which sterically blocks both Pol II and MED26 binding via a disordered region of MED13.

1. 2000 Medium

   Before MED26's mechanism was known, structural analysis of a homologous domain established the architectural template for its functional region.

   Evidence NMR structure of yeast TFIIS domain I with homology modeling of the CRSP70 (MED26) domain

   PMID:10811649

   Open questions at the time

   • CRSP70/MED26 structure inferred only by homology, not directly solved here
   • Functional role of the conserved charged surface patch untested
   • No partner interactions demonstrated
2. 2011 High

   Established the central function of MED26 as a molecular switch coupling initiation to elongation by exchanging TFIID for the super elongation complex on its NTD.

   Evidence Co-IP, domain mapping with mutants, ChIP, and transcription assays in human cells

   PMID:21729782

   Open questions at the time

   • Structural basis of the competitive exchange not resolved
   • Kinetics and trigger of the switch in vivo unknown
   • Generality across gene classes not addressed
3. 2014 High

   Extended MED26 function beyond Mediator/elongation by showing a heterochromatin connection through its C-terminus, implying a role outside active transcription.

   Evidence Co-IP, domain mapping, immunofluorescence on Drosophila polytene chromosomes, and null allele analysis

   PMID:24820420

   Open questions at the time

   • Functional consequence of MED26-HP1 binding at heterochromatin unresolved
   • Whether HP1 interaction is conserved in mammals untested
   • Relationship between heterochromatin pool and elongation pool unclear
4. 2015 High

   Generalized the switch model to snRNA genes by showing the NTD recruits the little elongation complex via EAF, distinguishing gene-class-specific elongation factor choice.

   Evidence Co-IP, ChIP-seq, siRNA knockdown, and transcription assays

   PMID:25575120

   Open questions at the time

   • What determines SEC versus LEC selection at a given gene is unknown
   • Direct competition between LEC and TFIID not structurally defined
5. 2017 High

   Provided the structural and energetic basis for the switch by showing TAF7 and EAF1 compete for the same NTD groove with comparable micromolar affinities.

   Evidence NMR solution structure, chemical shift perturbation, alanine mutagenesis, and binding affinity measurements

   PMID:28893534

   Open questions at the time

   • How comparable affinities are biased toward exchange in vivo unclear
   • Full-length protein contributions beyond peptides untested
6. 2021 Medium

   Confirmed a robust biochemical association between MED26 and TFIID, reinforcing the initiation-stage interaction inferred from earlier functional work.

   Evidence Biochemical co-purification and chromatography fractionation of TFIID

   PMID:33836240

   Open questions at the time

   • Interaction characterized only biochemically, not structurally here
   • Stoichiometry and regulation not addressed
7. 2024 Medium

   Defined how MED26 incorporation into core Mediator is regulated, showing the CKM sterically occludes the MED26/Pol II binding site.

   Evidence Cryo-EM of human complete Mediator and CKM (preprint)

   Open questions at the time

   • Preprint, no functional mutagenesis of the occluded MED26 site
   • Dynamics of CKM displacement to permit MED26 binding not shown
8. 2024 Medium

   Revealed a context-dependent, condensate-based mode of MED26 action during differentiation, distinct from canonical Mediator co-occupancy.

   Evidence ChIP-seq, knockdown/knockout erythroid differentiation assays, live-cell condensate imaging, and Co-IP of pausing factors (preprint)

   Open questions at the time

   • Preprint, single lab
   • Molecular determinants of condensate formation undefined
   • Why MED26 occupancy diverges from MED1 mechanistically unclear

• How MED26 integrates its initiation-to-elongation switching, heterochromatin association, and condensate formation into context-specific gene regulatory outcomes remains unresolved.
• No unified model linking the three activities
• In vivo trigger of the TFIID-to-elongation-complex exchange unknown
• Mammalian relevance of HP1 interaction untested